Oct. 18 Company Quick Takes: AZ-Daiichi, Sanofi, Merck, Lilly and AFTD-Target ALS

Priority Review for breast cancer ADC from Daiichi, AZ
AstraZeneca plc (LSE:AZN; NYSE:AZN) and Daiichi Sankyo Co. Ltd. (Tokyo:4568) said FDA accepted and granted Priority Review to a BLA

Read the full 289 word article

How to gain access

Continue reading with a
two-week free trial.